Elicio Therapeutics

IN THE PRESS

Deals

Elicio Therapeutics Announces $7.0 Million Private Placement Financing

December 22, 2023

·

4 min read

Genetown

Elicio Therapeutics to Present at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

December 4, 2023

·

1 min read

Business

Elicio Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

November 9, 2023

·

13 min read

Drug Development

Elicio Therapeutics Presents Updated Preliminary Immunogenicity Data from the Ongoing Phase 1 Study of ELI-002 and New Preclinical Data on ELI-007 and ELI-008 at the Society for Immunotherapy of Cancer (SITC 2023) Annual Meeting

November 3, 2023

·

11 min read

Genetown

Elicio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer’s (SITC 2023) Annual Meeting

October 11, 2023

·

7 min read

JOBS